Serum inflammatory markers in diabetic retinopathy

Area of Science:

• Ophthalmology
• Immunology
• Diabetology

Background:

• Diabetic retinopathy (DR) is a leading cause of vision loss.
• Inflammation is increasingly recognized as a key factor in DR development and progression.
• Specific serum biomarkers associated with DR severity require further investigation.

Purpose of the Study:

• To investigate the association between serum levels of various chemokines, cytokines, cell adhesion molecules, and growth factors and the severity of diabetic retinopathy.
• To examine the presence of selected inflammatory factors within retinal tissues of individuals with diabetic retinopathy.

Main Methods:

• Serum samples from 93 subjects were analyzed for 14 factors, including chemokines (e.g., RANTES, SDF-1alpha), IL-6, ICAM-1, VCAM-1, and VEGF.
• Logistic regression was used to correlate factor levels with DR severity, age, sex, HbA1c, cholesterol, creatinine, diabetes duration, and macular edema.
• Immunohistochemistry was performed on autopsy-obtained retinal tissues from a diabetic donor and a control to detect RANTES, MCP-1, and ICAM-1.

Main Results:

• Significantly elevated serum levels of RANTES and SDF-1alpha were observed in patients with at least severe nonproliferative diabetic retinopathy compared to those with milder forms (P < 0.001 and 0.007).
• Immunohistochemical analysis revealed positive staining for MCP-1 and RANTES in the inner retina and strong ICAM-1 staining throughout the retina of the diabetic donor eye.
• Normal retinal tissue showed minimal reactivity to these markers.

Conclusions:

• Elevated serum levels of specific chemokines are significantly associated with the severity of diabetic retinopathy.
• The presence of these chemokines and cell adhesion molecules in retinal tissue supports their role in the inflammatory processes underlying diabetic retinopathy.
• These findings highlight the potential of targeting inflammatory pathways for managing diabetic retinopathy.